The role NT-proBNP plays in the diagnosis and management of Congestive Heart Failure
kwietnia 21, 2021
This is a scientific webinar sponsored by Radiometer Pacific, and the speakers are Mr Guillaume Galpy, Principal Specialist, Immunoassay, Radiometer and Associate Professor David Prior, Deputy Director of Cardiology, Director of Non-invasive Cardiac Imaging and Head of the Heart Failure Clinic at St Vincent’s Hospital, Melbourne.
About this webinar
The speakers will review the challenges with BNP vs NTproBNP testing and will share their perspectives and experiences from both years of diagnosis and management of Congestive Heart Failure.
During this webinar, you will have the opportunity to engage in a live Q&A with the speakers, and participate in a Poll about Cardiac Biomarkers.
About the speakers
Guillaume Galpy is Global Market Development Manager for immunoassay at Radiometer Medical. He graduated in Biology and Marketing from the University of Nice and Lyon in France.
Having worked on acute care testing for more than 24 years, Guillaume has been a global industry expert in the field of Immunoassay, and has worked in senior sales, marketing, technical and scientific roles for several Global In Vitro Diagnostic Companies.
Associate Professor David Prior
Associate Professor David Prior is Deputy Director of Cardiology, Director of Non-invasive Cardiac Imaging and Head of the Heart Failure Clinic at St Vincent’s Hospital, Melbourne. After training in cardiology at the Alfred Hospital, he completed a PhD in heart failure at the Baker Heart Research Institute and subsequently an imaging fellowship at the Cleveland Clinic Foundation, USA.
He has worked at St Vincent’s Hospital since 2000 and also holds a position as Associate Professor at the University of Melbourne.
Major clinical and research interests are in heart failure management, echocardiography, cardiac MRI, sports cardiology and pulmonary hypertension. He has published over 150 scientific papers and is a fellow of the American College of Cardiology and the American Society of Echocardiography. He is a former board member of the Cardiac Society of Australia & New Zealand.
Who should attend?
- Cardiology Registrars
- Lab directors (and/or assistant directors)
- Lab managers (supervisory and/or non-supervisory)
- Point-of-care coordinators/managers
- Other laboratory professionals overseeing and/or carrying out Cardiac Biomarker testing